GURUFOCUS.COM » STOCK LIST » Technology » Software » Amesite Inc (NAS:AMST) » Definitions » Change In Payables And Accrued Expense

Amesite (Amesite) Change In Payables And Accrued Expense : $0.01 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Amesite Change In Payables And Accrued Expense?

Amesite's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $0.05 Mil. It means Amesite's Accounts Payable & Accrued Expense increased by $0.05 Mil from Dec. 2023 to Mar. 2024 .

Amesite's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was $-0.19 Mil. It means Amesite's Accounts Payable & Accrued Expense declined by $0.19 Mil from Jun. 2022 to Jun. 2023 .


Amesite Change In Payables And Accrued Expense Historical Data

The historical data trend for Amesite's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amesite Change In Payables And Accrued Expense Chart

Amesite Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Change In Payables And Accrued Expense
0.08 -0.01 -0.08 0.09 -0.19

Amesite Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.01 0.03 -0.08 0.05

Amesite Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amesite Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Amesite's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Amesite (Amesite) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Amesite Inc (NAS:AMST) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
N/A
Address
607 Shelby Street, Suite 700, PMB 214, Detroit, MI, USA, 48226
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology-driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are businesses, universities and colleges, and K-12 schools.
Executives
Ann Marie Sastry director, officer: Chief Executive Officer C/O LOLA ONE ACQUISITION CORPORATION, 2255 GLADES ROAD, SUITE 324A, BOCA RATON FL 33431
Gilbert S Omenn director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
J Michael Losh director H.B. FULLER COMPANY, P.O. BOX 64683, ST. PAUL MN 55164-0683
Richard Ogawa director 2953 BUNKER HILL LANE, SUITE 300, SANTA CLARA CA 95054
Anthony M. Barkett director C/O LOLA ONE ACQUISITION CORPORATION, 2255 GLADES ROAD, SUITE 324A, BOCA RATON FL 33431
George Parmer director 102 WEST BAKER STREET, PLANT CITY FL 33563
Sherrie Farrell officer: Chief Financial Officer 607 SHELBY STREET, SUITE 700, PMB 214, DETROIT MI 48226
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Mark N. Tompkins 10 percent owner APP. 1, VIA GUIDINO 23, LUGANO-PARADISO V8 6900
Matthew Kern officer: Chief Financial Officer 607 SHELBY STREET, SUITE 700 PMB 214, DETROIT MI 48226
Richard D. Dibartolomeo officer: Chief Financial Officer C/O AMESITE INC., 205 EAST WASHINGTON STREET, SUITE B, ANN ARBOR MI 48104
Barbie Brewer director 205 EAST WASHINGTON STREET, SUITE B, ANN ARBOR MI 48104